Recently Published Drug Patents
Drug mentioned:
SODIUM THIOSULFATE
US20230390330A1
METHOD FOR REDUCING OTOTOXICITY IN PEDIATRIC PATIENTS RECEIVING PLATINUM-BASED CHEMOTHERAPY
What are the use cases of SODIUM THIOSULFATE?
TREATMENT OF ACUTE CYANIDE POISONING THAT IS JUDGED TO BE LIFE THREATENING, SODIUM THIOSULFATE INJECTION IS INDICATED FOR SEQUENTIAL USE WITH SODIUM NITRITE FOR THE TREATMENT OF ACUTE CYANIDE POISONIN...
Oregon Health & Science University
Dec 07, 2023
Drug mentioned:
SODIUM NITRITE
US20230392068A1
SAND CONSOLIDATION USING ASPHALTENE/TAR WITH SOLVENTS AND ADSORPTION SYSTEM
What are the use cases of SODIUM NITRITE?
SODIUM NITRITE INJECTION IS INDICATED FOR SEQUENTIAL USE WITH SODIUM THIOSULFATE FOR THE TREATMENT OF ACUTE CYANIDE POISONING
SAUDI ARABIAN OIL COMPANY
Dec 07, 2023
Drug mentioned:
EPINEPHRINE
US20230390218A1
EPINEPHRINE SPRAY FORMULATIONS
What are the use cases of EPINEPHRINE?
INCREASING MEAN ARTERIAL BLOOD PRESSURE IN ADULT PATIENTS WITH HYPOTENSION ASSOCIATED WITH SEPTIC SHOCK, INDUCTION AND MAINTENANCE OF MYDRIASIS DURING INTRAOCULAR SURGERY, EMERGENCY TREATMENT OF ALLER...
Dec 07, 2023
Drug mentioned:
DOCETAXEL
US11833128B2
Ketone carbonyl-containing hydrophobic antitumor drug and conjugate thereof as well as nano preparation containing conjugate, preparation method therefor, and application thereof
What are the use cases of DOCETAXEL?
TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER AFTER FAILURE OF PRIOR PLATINUM-BASED CHEMOTHERAPY, USE IN COMBINATION WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE FOR AD...
Jiangsu Jibeier Pharmaceutical Co. Ltd.
Dec 05, 2023
Drug mentioned:
EPINEPHRINE
US11833336B2
Syringe and kit for administering predetermined specific epinephrine doses
What are the use cases of EPINEPHRINE?
INCREASING MEAN ARTERIAL BLOOD PRESSURE IN ADULT PATIENTS WITH HYPOTENSION ASSOCIATED WITH SEPTIC SHOCK, INDUCTION AND MAINTENANCE OF MYDRIASIS DURING INTRAOCULAR SURGERY, EMERGENCY TREATMENT OF ALLER...
Dec 05, 2023
Drug mentioned:
OMEPRAZOLE
US11826359B2
Pediatric suspension formulation
Xeolas Pharmaceuticals Ltd.
Nov 28, 2023